Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Hui Liu

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Molecular Neurobiology|March 10, 2016
Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta ClearanceYe-Ran Wang, Qing-Hua Wang, Tao Zhang, et al.
Journal of Alzheimer'S Disease : JAD|March 28, 2022
Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's DiseaseJie-Ming Jian, Dong-Yu Fan, Yuan Cheng, et al.
Molecular Neurobiology|June 13, 2023
Associations of Blood and Cerebrospinal Fluid Aβ and tau Levels with Renal FunctionHao-Lun Sun, Xiu-Qing Yao, Li Lei, et al.
The Journal of Prevention of Alzheimer'S Disease|March 30, 2025
Fingolimod ameliorates amyloid deposition and neurodegeneration in APP/PS1 mouse model of Alzheimer's diseaseMeng-Ting Wang, Zi-Cheng Hu, Yang Xiang, et al.
Neurotoxicity Research|February 7, 2020
Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's DiseaseZhong-Yuan Yu, Wei-Wei Li, Hai-Mei Yang, et al.
Nature Aging|July 10, 2024
Tracking cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infectionYu-Hui Liu, Quan-Xin Wu, Qing-Hua Wang, et al.
Influenza and Other Respiratory Viruses|November 19, 2021
Some characteristics of clinical sequelae of COVID-19 survivors from Wuhan, China: A multi-center longitudinal studyXian Chen, Ying Li, Tong-Ren Shao, et al.
Neurotoxicity Research|August 6, 2015
Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary DiseaseXian-Le Bu, Guo-Qiang Cao, Lin-Lin Shen, et al.
Acta Neuropathologica|September 14, 2015
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's diseaseYang Xiang, Xian-Le Bu, Yu-Hui Liu, et al.
Molecular Neurobiology|July 3, 2014
Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's DiseaseYu-Hui Liu, Shu-Sheng Jiao, Ye-Ran Wang, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Molecular Neurobiology|March 10, 2016
Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta ClearanceYe-Ran Wang, Qing-Hua Wang, Tao Zhang, et al.
Journal of Alzheimer'S Disease : JAD|March 28, 2022
Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's DiseaseJie-Ming Jian, Dong-Yu Fan, Yuan Cheng, et al.
Molecular Neurobiology|June 13, 2023
Associations of Blood and Cerebrospinal Fluid Aβ and tau Levels with Renal FunctionHao-Lun Sun, Xiu-Qing Yao, Li Lei, et al.
The Journal of Prevention of Alzheimer'S Disease|March 30, 2025
Fingolimod ameliorates amyloid deposition and neurodegeneration in APP/PS1 mouse model of Alzheimer's diseaseMeng-Ting Wang, Zi-Cheng Hu, Yang Xiang, et al.
Neurotoxicity Research|February 7, 2020
Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's DiseaseZhong-Yuan Yu, Wei-Wei Li, Hai-Mei Yang, et al.
Nature Aging|July 10, 2024
Tracking cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infectionYu-Hui Liu, Quan-Xin Wu, Qing-Hua Wang, et al.
Influenza and Other Respiratory Viruses|November 19, 2021
Some characteristics of clinical sequelae of COVID-19 survivors from Wuhan, China: A multi-center longitudinal studyXian Chen, Ying Li, Tong-Ren Shao, et al.
Neurotoxicity Research|August 6, 2015
Serum Amyloid-Beta Levels are Increased in Patients with Chronic Obstructive Pulmonary DiseaseXian-Le Bu, Guo-Qiang Cao, Lin-Lin Shen, et al.
Acta Neuropathologica|September 14, 2015
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's diseaseYang Xiang, Xian-Le Bu, Yu-Hui Liu, et al.
Molecular Neurobiology|July 3, 2014
Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's DiseaseYu-Hui Liu, Shu-Sheng Jiao, Ye-Ran Wang, et al.
Pageof 12